OHSU in the news

New Trials in Breast Cancer: Could Your Patient Benefit?

Medscape September 16, 2024
A Medscape article highlights new clinical trials available to patients with breast cancer, including a study led by Kerri Winters-Stone, Ph.D., called “Exercising Together.” The study seeks to determine whether exercising together prevents decline in a couple's physical and mental health as one partner undergoes radiation therapy.

How redefining 'normal' iron levels could help women's health

Canadian Broadcasting Company September 14, 2024
Amy Cantor, M.D., author of new guidelines that found insufficient evidence to support screening and treating iron deficiency in pregnant people without symptoms of iron deficiency, is quoted in a Canadian Broadcasting Company article on how redefining "normal" iron levels could help women's health: "Conflicting guidelines, variable clinical practices, changing cutoffs for diagnosis, and access to health care services may affect the accuracy of reported rates of screening and supplementation in all populations and in those at risk for experiencing health disparities."

Everyday Heroes: Beaverton teen teaches peers to use artificial intelligence responsibly

KATU-TV September 13, 2024
KATU-TV profiles a West View high school senior who recently completed an internship in data science at OHSU who is teaching his peers responsible use of AI: "Doctors are using AI and machine learning -- sports, statisticians, they're using AI, too. It's everywhere, and I think that the younger these kids realize this is the future and it's a part of everything we do, it will be a lot more helpful for them to get a head start on it and be prepared for what's coming. The lab I worked in, the whole goal was to create a new vaccine for malaria that's affordable and cheaper and more effective, so the work I'm doing could literally save lives."

How artificial intelligence is aiding in cancer research

KGW-TV September 13, 2024
At OHSU's Knight Cancer Institute, researchers are focused on finding ways to detect cancer earlier and produce more targeted treatments for individual types of cancer. But with so much variety in cancers, let alone the human body, the amounts of data they need to gather and analyze is mind-bogglingly vast.

Top doc at OHSU's Knight Cancer Institute is on the bleeding edge of research

KGW-TV September 12, 2024
In a wide-ranging, two-part interview, Brian Druker, M.D., discusses highlights from his career, advancements from the OHSU Knight Cancer Institute, and how artificial intelligence will play a role in the future of cancer research. When asked about Gleevec, the drug he developed, he says: “But the wealth that I have is that at least once a week I get an email in my inbox from a patient who has benefited from this medication, and what a remarkable reward to get an email at the end of a long week that said, 'Thank you for this drug, and here's all the incredible things I've done over the last decade.'"
See more stories